» Articles » PMID: 26172304

Exposure to ALS-FTD-CSF Generates TDP-43 Aggregates in Glioblastoma Cells Through Exosomes and TNTs-like Structure

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Jul 15
PMID 26172304
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent a continuum of devastating neurodegenerative diseases, characterized by transactive response DNA-binding protein of 43 kDa (TDP-43) aggregates accumulation throughout the nervous system. Despite rapidly emerging evidence suggesting the hypothesis of 'prion-like propagation' of TDP-43 positive inclusion in the regional spread of ALS symptoms, whether and how TDP-43 aggregates spread between cells is not clear. Herein, we established a cerebrospinal fluid (CSF)-cultured cell model to dissect mechanisms governing TDP-43 aggregates formation and propagation. Remarkably, intracellular TDP-43 mislocalization and aggregates were induced in the human glioma U251 cells following exposure to ALS-FTD-CSF but not ALS-CSF and normal control (NC) -CSF for 21 days. The exosomes derived from ALS-FTD-CSF were enriched in TDP-43 C-terminal fragments (CTFs). Incubation of ALS-FTD-CSF induced the increase of mislocated TDP-43 positive exosomes in U251 cells. We further demonstrated that exposure to ALS-FTD-CSF induced the generations of tunneling nanotubes (TNTs)-like structure and exosomes at different stages, which mediated the propagation of TDP-43 aggregates in the cultured U251 cells. Moreover, immunoblotting analyses revealed that abnormal activations of apoptosis and autophagy were induced in U251 cells, following incubation of ALS-CSF and ALS-FTD-CSF. Taken together, our data provide direct evidence that ALS-FTD-CSF has prion-like transmissible properties. TNTs-like structure and exosomes supply the routes for the transfer of TDP-43 aggregates, and selective inhibition of their over-generations may interrupt the progression of TDP-43 proteinopathy.

Citing Articles

Enhanced secretion of the amyotrophic lateral sclerosis ALS-associated misfolded TDP-43 mediated by the ER-ubiquitin specific peptidase USP19.

Picard F, Nonaka T, Belotti E, Osseni A, Errazuriz-Cerda E, Jost-Mousseau C Cell Mol Life Sci. 2025; 82(1):76.

PMID: 39948244 PMC: 11825969. DOI: 10.1007/s00018-025-05589-w.


Intraventricular Administration of Exosomes from Patients with Amyotrophic Lateral Sclerosis Provokes Motor Neuron Disease in Mice.

Stavrovskaya A, Voronkov D, Pavlova A, Olshanskiy A, Belugin B, Ivanova M Acta Naturae. 2025; 16(4):73-80.

PMID: 39877010 PMC: 11771849. DOI: 10.32607/actanaturae.27499.


Approaches and Challenges in Characterizing the Molecular Content of Extracellular Vesicles for Biomarker Discovery.

Kumari S, Lausted C, Scherler K, Ng A, Lu Y, Lee I Biomolecules. 2025; 14(12.

PMID: 39766306 PMC: 11674167. DOI: 10.3390/biom14121599.


Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.

Jeon S, Jeon Y, Lim J, Kim Y, Cha B, Kim W Signal Transduct Target Ther. 2025; 10(1):4.

PMID: 39757214 PMC: 11701242. DOI: 10.1038/s41392-024-02070-1.


Secretome - the role of extracellular vesicles in the pathogenesis and therapy of neurodegenerative diseases.

Sulek A Postep Psychiatr Neurol. 2024; 33(3):147-162.

PMID: 39678458 PMC: 11635433. DOI: 10.5114/ppn.2024.144686.


References
1.
Cohen T, Lee V, Trojanowski J . TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med. 2011; 17(11):659-67. PMC: 3202652. DOI: 10.1016/j.molmed.2011.06.004. View

2.
Polymenidou M, Cleveland D . The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011; 147(3):498-508. PMC: 3220614. DOI: 10.1016/j.cell.2011.10.011. View

3.
Le Verche V . [Familial and sporadic ALS astrocytes activate necroptosis in motor neurons]. Med Sci (Paris). 2014; 30(8-9):748-50. DOI: 10.1051/medsci/20143008011. View

4.
Sasaki S . Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2011; 70(5):349-59. DOI: 10.1097/NEN.0b013e3182160690. View

5.
Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T . Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013; 4(1):124-34. DOI: 10.1016/j.celrep.2013.06.007. View